June 7, 2019 / 5:06 AM / in 14 days

BRIEF-Polyphor Presents New In-Vivo Efficacy And Tolerability Data

June 7 (Reuters) - Polyphor AG:

* POLYPHOR PRESENTS NEW IN-VIVO EFFICACY AND TOLERABILITY DATA FOR A POTENTIAL INHALED ADMINISTRATION OF ITS LEAD ANTIBIOTIC MUREPAVADIN AT EUROPEAN CYSTIC FIBROSIS CONFERENCE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below